Oregon Health Authority - 2022 follow-up report
- Next1 of 2
|Title:||Oregon Health Authority: constraints on Oregon's prescription drug monitoring program limit the state's ability to help address opioid misuse and abuse.|
Constraints on Oregon's prescription drug monitoring program limit the state's ability to help address opioid misuse and abuse.
Recommendation follow-up report Oregon Health Authority some constraints still remain in Oregon's Prescription Drug Monitoring Program.
Oregon Health Authority some constraints still remain in Oregon's Prescription Drug Monitoring Program.
Oregon Audits Division,, author,, issuing body.
Oregon Health Authority
|Type of Resource:||text|
|Publisher:||Secretary of State, Oregon Audits Division|
|Place of Publication:||Salem, OR :|
|Extent:||1 online resource|
Covers OCLC #1333965157, OCLC #1078785684
Title from PDF cover (viewed on December 12, 2018).
This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.
Includes bibliographical references.
Mode of access: Internet from the Oregon Government Publications Collection.
Text in English.
Oregon Health Authority -- Auditing
Oregon Prescription Drug Monitoring Program -- Auditing
Opioid abuse -- Oregon -- Prevention -- Evaluation
Opioid abuse -- Prevention -- Government policy -- Oregon
Drugs -- Prescribing -- Oregon -- Data processing -- Evaluation
Drugs -- Prescribing -- Data processing -- Government policy -- Oregon
|Held by:||Oregon State Library|
|Restrictions on Access:||http://rightsstatements.org/vocab/CNE/1.0/|
|Is Part of Series:||Secretary of State audit report ; no. 2022-17.|
|Is Part of Series:||Secretary of State audit report ; no. 2018-40.|